The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Advances in therapeutic CRISPR/Cas9 genome editing
Open accessAbstract
Targeted nucleases are widely used as tools for genome editing. Two years ago the clustered regularly interspaced short palindromic repeat (CRISPR)-associated Cas9 nuclease was used for the first time, and since then has largely revolutionized the field. The tremendous success of the CRISPR/Cas9 genome editing tool is powered by the ease design principle of the guide RNA that targets Cas9 to the desired DNA locus, and by the high specificity and efficiency of CRISPR/Cas9-generated DNA breaks. Several studies recently used CRISPR/Cas9 to successfully modulate disease-causing alleles in vivo in animal models and ex vivo in somatic and induced pluripotent stem cells, raising hope for therapeutic genome editing in the clinics. In this review, we will summarize and discuss such preclinical CRISPR/Cas9 gene therapy reports.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CRISPR/Cas9 can change the cancer-related genes and improve the ability of immune cells to recognize and get rid of cancer cells, opening up new avenues for cancer immunotherapy.[6]”
From A Review of Research on CRISPR/Cas9 Gene Editing Technology in Disease Treatment (2024) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–257 of 257
A Review of Research on CRISPR/Cas9 Gene Editing Technology in Disease Treatment
Jing, X. (2024) · Academic Journal of Science and Technology · doi:10.54097/5crj2x50
“[6] CRISPR/Cas9 technology allows for screening cancer cells to determine their gene specificity.”
dos Santos, S. N. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-20042016-103856
The role of Pygo2 during intestinal tumor initiation and progression in vivo
Talla, S. B. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5646
Finding Treatments for Genetic Metabolic Disease
Vernon, H. J. (2016) · Current Pediatrics Reports · doi:10.1007/s40124-016-0113-4
基于CRISPR/Cas9基因编辑技术的人类遗传疾病基因治疗相关研究进展
门, 可., 段, 醒., 杨, 阳., & 魏, 于. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00169
秦, 舟., 门, 可., 徐, 珽., 何, 治., 魏, 于., & 杨, 阳. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00202
The Ethics of Therapeutic Gene Editing Research
Jun, B.-O. (2016) · Korean Journal of Medical Ethics · doi:10.35301/ksme.2016.19.1.47
Torres, C. B. B., & Pessoa, W. S. (2018) · Jornal Interdisciplinar de Biociências · doi:10.26694/jibi.v3i1.6258
Access denied : A closer look at anti-phage defense mechanisms
Vlot, M. (2018) · doi:10.18174/449991 · Cited by 1
Studies in Trypsin as an Alarm Substance in Zebrafish
Alsrhani, A. (2018) · doi:10.12794/metadc1248500
CRISPRing or RISKing? Dangers Arising from Gene Editing with CRISPR-Cas9
Giakountis, A. (2018) · Medicinal & Analytical Chemistry International · doi:10.23880/macij-16000114
CRISPR‐Cas9 : A New Tool for Gene Therapy
Sharma, S., Maiti, S., & Chakraborty, D. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0026629
Application of Biotechnology in Diagnosis and Treatment of Human Genetic Disorders
ASHINE, T. A., & Tessema, T. S. (2019) · Advances in life science and technology · doi:10.7176/alst/76-02
Can Hsp Targeted Gene Therapy Be a New Hope for Gliomas?
Uçar, E. Ö., Şengelen, A., Güngör, E., Mertoğlu, E., Pekmez, M., & Arda, N. (2019) · Heat shock proteins · doi:10.1007/978-3-030-24285-5_13
Maghami, M. G. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8152
Madariaga, I., Duque-Restrepo, J. C., Ayala, P., & García‐Robles, R. (2020) · IATREIA · doi:10.17533/udea.iatreia.56 · Cited by 1
Neuropharmacology: Looking Forward to the Future
Siju, E. N., & Rajalakshmi, G. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-5167-3_10
Highly efficient multiplex genetic engineering of porcine primary fetal fibroblasts
Klapholz, B., Levy, H., Kumbha, R., Hosny, N., D’Angelo, M. E., Hering, B. J., & Burlak, C. (2020) · Surgery Open Science · doi:10.1016/j.sopen.2020.11.003
Mimoune, N., Benadjel, O., Baazizi, R., Kelef, D., & Kaidi, R. (2021) · Veterinarska stanica · doi:10.46419/vs.52.4.9
Using CRISPR-Cas9 for Therapeutic Protein Production (Review Article)
Khan, A. U., & Ullah, Z. (2021) · Asian Journal of Pharmacy Nursing and Medical Sciences · doi:10.24203/ajpnms.v9i1.6115
Investigating the Use of CRISPR/Cas9 for Genetic Screens in Drosophila
Ng, W. A. (2021) · UWSpace (University of Waterloo)
Genetic causes and stem-cell-based therapeutic strategies in neuromuscular diseases
Guo, L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210623lg
Humanos sem natureza : as técnicas de reprodução assistida e o anonimato no parentesco
Novaes, T. O. D. S. (2016) · doi:10.26512/2016.11.t.23225
Karyotype diversification in colorectal cancer
Bollen, Y. (2022) · doi:10.3990/1.9789036553506
Blank, W., Heinzmann, A., Annema, J. T., Veseliç, M., & Rabe, K. F. (2022) · Springer eBooks · doi:10.1007/978-3-031-09442-2_6
EDITING OF THE HUMAN GENOME – LEGAL ASPECTS OF CLINICAL APPLICATION
ПЕСТРИКОВА, А. А. (2023) · International Congress "The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies" · doi:10.21603/-i-ic-104
CRISPR/Cas9 Systems and Gene Editing Technology
Gök, Ö., Beyaz, S., & Aslan, A. N. (2023) · Osmaniye Korkut Ata Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.47495/okufbed.1085220
Epigenetics and Genetics of Schizophrenia
Ganesh, D. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v11i2.2629
Introduction: regulation of biotechnology, between anxieties and trust in scientific progress
Herdegen, M. (2023) · Edward Elgar Publishing eBooks · doi:10.4337/9781035302055.00007
SALMONELLA CRISPR-Cas SİSTEMİ’NİN TEMEL ÖZELLİKLERİ
ERDOĞAN, Ö. (2023) · Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni · doi:10.38137/vftd.1208878
Unexpected extra exon skipping in the DYSF gene during restoring the reading frame by CRISPR/Cas9
Levchenko, O. A., Panchuk, I., Kochergin-Nikitsky, K. S., Petrova, I. O., Nagieva, S. E., Pilkin, M., Антонович, Я. И., Smirnikhina, S., Deev, R. V., & Лавров, А. В. (2023) · Biosystems · doi:10.1016/j.biosystems.2023.105072
Júnior, Y. F. D. M., & da Costa, R. S. L. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n1-088
Molecular Methods for Detecting Antiparasitic Resistance
Sajid, M. S., Faiz, S., Qasim, M., Jan, I., Ahmad, S., Fouad, D., & Ataya, F. S. (2024) · CABI eBooks · doi:10.1079/9781800622807.0007
Construction of vof16 gene knockout rat with CRISPR/Cas9
Dan, Q., & Zhang, W. (2024) · New cell · doi:10.61958/ncox2261
Оценка рисков генетической технологии CRISPR/Cas9
ПЕСТРИКОВА, А. А., & Kholopova, E. N. (2020) · Современное право. · doi:10.25799/ni.2020.68.12.014
Nucleic Acid-Based Systems for Regenerative Medicine
Martín, L., & Grzela, D. P. (2025) · Springer eBooks · doi:10.1007/978-3-031-87744-5_8
CRISPR-Cas9 Technology: in Biotechnology a Breakthrough Innovation
Özanatça, L., & Işık, R. (2025) · Hayvansal Üretim · doi:10.29185/hayuretim.1628222
Genome Editing: Breakthroughs in Double-Strand Break (DSB) Repair and What’s Next
Wang, Z. (2025) · International journal of high school research · doi:10.36838/v7i7.38
Application of CRISPR-Cas9 technology in farm animals: A comprehensive review
Pritham, P. P., Siri, T. S., Madala, G., Sindhuri, A. H., Kancharla, S., Kolli, P., Mandadapu, G., Rath, P. K., Mishra, B. P., & Jena, M. K. (2025) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2025.033.3.07 · Cited by 1
Pharmacogenomics and CRISPR-based therapies
Fatima, M., Tariq, I., Tariq, A., Talib, S., Fatima, M., Shehzadi, M., & Aqib, A. I. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.009
Tarone, A. M., & Singh, B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13961-1.00010-1
Tang, A., Zhu, M., Zhu, J., Zhang, D., Zhu, S., Wang, X., Meng, C., Li, C., & Liu, G. (2023) · Figshare · doi:10.6084/m9.figshare.22767260
Kim, Y., Kim, G.-J., & Kwon, O. S. (2025) · Applied Science and Convergence Technology · doi:10.5757/asct.2025.34.5.148
A Panoramic View on Neurodegeneration, Its Connection with Microbiota and Its Therapeutics
Ganatra, T. H., & Tirgar, P. (2026) · International Journal of Scientific Research in Science and Technology · doi:10.32628/ijsrst25126403
CRISPR-Cas9 Teknolojisi: Biyoteknolojide Devrim Niteliğinde Bir İnovasyon
Özanatça, L., & Işık, R. (2025) · DergiPark (Istanbul University)
Aptamers in Osteosarcoma: New Paths for Diagnosis and Treatment
Awad, G., Boutros, M., Chartouni, A., & Pretell-Mazzini, J. (2026) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206398665251010093110
The role of the serum response factor in the pathogenesis of Huntington's disease
Awada, A. (2021) · theses.fr (ABES) · doi:10.70675/fabef4b5z9d78z440bz99f2z9be7d0814a03
The Mechanism of FN3K in Diseases and Its Targeting Potential: A Focus on Cancer Treatment
张, 樑. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641408
Engineered targeted enhancement of translation in mammalian cell
Liu, J., Lv, Y., Zhou, Z., Huang, L., Lei, K., Tu, Z., Gong, C., Fang, Z., Wang, C., Wang, D., et al. (2026) · BMC Biology · doi:10.1186/s12915-026-02653-0
CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer
Mukherjee, S., Karati, D., Sarkar, S., Ash, D., Ganguly, S. C., Dutta, A., & Kesarla, R. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2732014
Metadata
- Authors
- Savić, N., & Schwank, G.
- Affiliations
- ETH Zurich (CH)
- Corresponding author
- Schwank, Gerald
- Venue
- Translational Research
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 168
- Pages
- 15-21
- ISSN
- 1878-1810 (ISSN-L)
- 1931-5244
- OpenAlex
- W1804459219
- Cited by
- 257
- References
- 52
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 29 · 2023: 21 · 2022: 26 · 2021: 25 · 2020: 31 · 2019: 25 · 2018: 26 · 2017: 22 · 2016: 25
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Translational research (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by-nc-nd)
- ETH Zürich Research Collection
- Funders
- Swiss National Science Foundation (31003A_160230)
- Human Frontiers in Science Program (LT000422/2012)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, genome editing, gene therapy, guide RNA, somatic cells, induced pluripotent stem cells, animal models
- MeSH terms
- CRISPR-Associated Protein 9, Animals, Bacterial Proteins, Endonucleases, Gene Expression Regulation, Genetic Therapy, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
